1
|
Allen KD, Ambrose KR, Booker SQ, Buck AN, Huffman KF. Non-Pharmacological Pain Management for Osteoarthritis: Review Update. Curr Rheumatol Rep 2025; 27:19. [PMID: 39969767 DOI: 10.1007/s11926-025-01185-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/05/2025] [Indexed: 02/20/2025]
Abstract
PURPOSE OF REVIEW To summarize the state of research and recent studies on non-pharmacological therapies for osteoarthritis (OA). RECENT FINDINGS High intensity interval training is an exercise-based intervention with some new, promising findings for people with OA. Among mind-body therapies, Tai Chi has the strongest evidence base to date. Diet + exercise has the strongest evidence for weight management in OA, with recent research focusing on maintenance of weight loss and non-calorie restrictive dietary patterns. Among psychological interventions, Cognitive Behavioral Therapy has the strongest evidence base, with some support for Acceptance and Commitment Therapy and mindfulness-based interventions. There is a clear role for non-pharmacological therapies for OA. Future research should address the effectiveness of interventions for which evidence is still limited, strategies for maintenance, heterogeneity of patients' responses to these therapies, and implementation in clinical and community settings.
Collapse
Affiliation(s)
- Kelli D Allen
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, CB# 7280, Chapel Hill, NC, 27599, USA.
- Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Center of Innovation to Accelerate Discovery and Practice Transformation, Durham VA Medical Center, Durham, NC, USA.
| | - Kirsten R Ambrose
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, CB# 7280, Chapel Hill, NC, 27599, USA
- Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Staja Q Booker
- College of Nursing, University of Florida, PO Box 100197, Gainesville, FL, USA
| | - Ashley N Buck
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, CB# 7280, Chapel Hill, NC, 27599, USA
- Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Katie F Huffman
- Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, CB# 7280, Chapel Hill, NC, 27599, USA
- Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| |
Collapse
|
2
|
Minghua S, Jiwei T, Lei Z, Jizhou Q, Zhiyuan L, Jiangang C. Wnt5a manipulate the progression of osteoarthritis via MMP-13 dependent signaling pathway. Medicine (Baltimore) 2024; 103:e40676. [PMID: 39686437 PMCID: PMC11651448 DOI: 10.1097/md.0000000000040676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Accepted: 11/06/2024] [Indexed: 12/18/2024] Open
Abstract
The object of this study was to propose a Wnt5a-matrix metalloproteinase (MMP)-13 dependent signaling axis for osteoarthritis (OA) progression. To this end, the chondrocytes were isolated from both OA patients and normal controls. The chondrocytes were treated with diverse concentrations of Wnt5a (0, 50, 100, and 200 ng/mL), respectively. The expression levels of Wnt5a, MMP-13, and Collagen type II were examined using reverse transcription-polymerase chain reaction and western blotting. At the same time, the cell proliferation and cell apoptosis of chondrocytes were also observed. Compared with control tissues, the activities of Wnt5a and MMP-13 were significantly enhanced in chondrocytes of OA patients. Treated with different concentrations of Wnt5a (0, 50, 100, and 200 ng/mL), chondrocyte cell proliferation was clearly downregulated. At the same time, the chondrocyte cell apoptosis was obviously accelerated. The expression pattern of Collagen type II was same as cell proliferation manner. Co-treatment of MMP-13 siRNA could significantly compensate the functions of Wnt-5a administration, suggesting MMP-13 was a direct target of Wnt-5a. Collectively, the study speculated a novel Wnt5a-MMP-13 molecular mechanism for OA progression and shed an innovative signaling axis for the disorder.
Collapse
Affiliation(s)
- Sun Minghua
- Department of Orthopaedics, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China
| | - Tian Jiwei
- Department of Orthopaedics, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China
| | - Zhang Lei
- Department of Orthopaedics, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China
| | - Qi Jizhou
- Department of Orthopaedics, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China
| | - Liu Zhiyuan
- Department of Orthopaedics, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China
| | - Cao Jiangang
- Department of Sports Injury and Arthroscopy, Tianjin Hospital, Tianjin, P.R. China
| |
Collapse
|
3
|
Fava S, Reiff S. Association of body mass index and blood pressure variability with 10-year mortality and renal disease progression in type 2 diabetes. Acta Diabetol 2024; 61:747-754. [PMID: 38438789 PMCID: PMC11101579 DOI: 10.1007/s00592-024-02250-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Accepted: 01/29/2024] [Indexed: 03/06/2024]
Abstract
BACKGROUND Variability in biological parameters may be associated with adverse outcomes. The aim of the study was to determine whether variability in body mass index (BMI) and blood pressure is associated with all-cause, cardiovascular mortality and cancer mortality or with renal disease progression in subjects with type 2 diabetes. METHODS The diabetes database was accessed, and all the information on patient visits (consultations) carried out in the study period (1 January 2008-31 December 2019) was extracted and linked to the laboratory database and the mortality register. RESULTS The total number of patients included in the study population was 26,261, of whom 54.4% were male. Median (interquartile range, IQR) age was 60.2 (51.8-68.3) years. The coefficient of variability of BMI was independently associated with increased all-cause and cardiovascular, but not cancer, mortality. Glycated haemoglobin (HbA1c) was associated with increased all-cause, cardiovascular, and cancer mortality as well as with renal progression. Variability in systolic blood pressure, diastolic blood pressure, and pulse pressure was associated with increased all-cause and cardiovascular mortality in bivariate, but not in multivariate, analyses. CONCLUSIONS Variability in BMI was associated with increased all-cause and cardiovascular, but not cancer, mortality in a large real-world contemporary population. Our results also confirm the association of HbA1c with increased all-cause, cardiovascular, and cancer mortality as well as with renal progression.
Collapse
Affiliation(s)
- Stephen Fava
- University of Malta Medical School, Msida, MSD 2090, Malta.
| | - Sascha Reiff
- Department for Policy in Health, Valletta, Malta
| |
Collapse
|
4
|
Van Gulick L, Saby C, Mayer C, Fossier E, Jaisson S, Okwieka A, Gillery P, Chenais B, Mimouni V, Morjani H, Beljebbar A. Biochemical and morpho-mechanical properties, and structural organization of rat tail tendon collagen in diet-induced obesity model. Int J Biol Macromol 2024; 254:127936. [PMID: 37939767 DOI: 10.1016/j.ijbiomac.2023.127936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Revised: 11/03/2023] [Accepted: 11/05/2023] [Indexed: 11/10/2023]
Abstract
We have investigated the impact of obesity on the structural organization, morpho-mechanical properties of collagen fibers from rat tail tendon fascicles (RTTFs). Polarized Raman microspectroscopy showed that the collagen bands 855, 875, 938, and 960 cm-1 as well as those 1631 and 1660 cm-1 were affected by diet. Mechanical properties exhibited an increase in the yield strength from control (CTRL) to high fat (HF) diet (9.60 ± 1.71 and 13.09 ± 1.81 MPa) (p < 0.01) and ultimate tensile strength (13.12 ± 2.37 and 18.32 ± 2.83 MPa) (p < 0.05) with no significant change in the Young's Modulus. During mechanical, the band at 875 cm-1 exhibited the most relevant frequency shift (2 cm-1). The intensity of those at 855, 875, and 938 cm-1 in HF collagen displayed a comparable response to mechanical stress as compared to CTRL collagen with no significant diet-related changes in the Full Width at Half Maximum. Second harmonic generation technique revealed i) similar fiber straightness (0.963 ± 0.004 and 0.965 ± 0.003) and ii) significant changes in fibers diameter (1.48 ± 0.07 and 1.52 ± 0.08 μm) (p < 0.05) and length (22.06 ± 2.38 and 29.00 ± 3.76 μm) (p < 0.001) between CTRL and HF diet, respectively. The quantification of advanced glycation end products (AGEs) revealed an increase in both carboxymethyl-lysine and total fluorescence AGEs from CTRL to HF RTTFs.
Collapse
Affiliation(s)
- Laurence Van Gulick
- Université de Reims Champagne-Ardenne, BioSpecT EA 7506, UFR de Pharmacie, 51096 Reims, France
| | - Charles Saby
- Université de Reims Champagne-Ardenne, BioSpecT EA 7506, UFR de Pharmacie, 51096 Reims, France
| | - Claire Mayer
- BiOSSE, Biology of Organisms, Stress, Health, Environment, Institut Universitaire de Technologie, Département Génie Biologique, Le Mans Université, 53020 Laval, France
| | - Emilie Fossier
- Université de Reims Champagne-Ardenne, BioSpecT EA 7506, UFR de Pharmacie, 51096 Reims, France
| | - Stéphane Jaisson
- Université de Reims Champagne-Ardenne, MEDyC CNRS UMR 7369, UFR de Médecine, 51097 Reims, France; Centre Hospitalo-Universitaire, Service de Biochimie-Pharmacologie-Toxicologie, Reims, France
| | - Anaïs Okwieka
- Université de Reims Champagne-Ardenne, MEDyC CNRS UMR 7369, UFR de Médecine, 51097 Reims, France
| | - Philippe Gillery
- Université de Reims Champagne-Ardenne, MEDyC CNRS UMR 7369, UFR de Médecine, 51097 Reims, France; Centre Hospitalo-Universitaire, Service de Biochimie-Pharmacologie-Toxicologie, Reims, France
| | - Benoît Chenais
- BiOSSE, Biology of Organisms, Stress, Health, Environment, UFR Sciences et Techniques, Le Mans Université, 72085 Le Mans, France
| | - Virginie Mimouni
- BiOSSE, Biology of Organisms, Stress, Health, Environment, Institut Universitaire de Technologie, Département Génie Biologique, Le Mans Université, 53020 Laval, France
| | - Hamid Morjani
- Université de Reims Champagne-Ardenne, BioSpecT EA 7506, UFR de Pharmacie, 51096 Reims, France
| | - Abdelilah Beljebbar
- Université de Reims Champagne-Ardenne, BioSpecT EA 7506, UFR de Pharmacie, 51096 Reims, France.
| |
Collapse
|